MACCALLINI, Cristina
 Distribuzione geografica
Continente #
NA - Nord America 5.776
EU - Europa 4.012
AS - Asia 3.759
SA - Sud America 369
AF - Africa 57
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 13.979
Nazione #
US - Stati Uniti d'America 5.617
SG - Singapore 1.426
CN - Cina 1.033
IT - Italia 939
IE - Irlanda 486
TR - Turchia 444
UA - Ucraina 427
SE - Svezia 424
RU - Federazione Russa 375
VN - Vietnam 331
GB - Regno Unito 313
BR - Brasile 308
FR - Francia 307
IN - India 265
DE - Germania 230
PL - Polonia 149
FI - Finlandia 120
CA - Canada 104
AT - Austria 69
BD - Bangladesh 50
ES - Italia 47
HK - Hong Kong 45
JP - Giappone 31
MX - Messico 30
CZ - Repubblica Ceca 25
BE - Belgio 22
NL - Olanda 21
LT - Lituania 20
ZA - Sudafrica 20
PK - Pakistan 16
AR - Argentina 15
KR - Corea 14
ID - Indonesia 12
IQ - Iraq 12
VE - Venezuela 12
AE - Emirati Arabi Uniti 9
CO - Colombia 9
CL - Cile 8
MY - Malesia 8
SA - Arabia Saudita 8
KE - Kenya 7
MA - Marocco 7
PH - Filippine 7
PT - Portogallo 7
TW - Taiwan 7
CH - Svizzera 5
EC - Ecuador 5
GR - Grecia 5
IL - Israele 5
JM - Giamaica 5
UZ - Uzbekistan 5
AU - Australia 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
EG - Egitto 4
ET - Etiopia 4
HR - Croazia 4
IR - Iran 4
JO - Giordania 4
PE - Perù 4
PY - Paraguay 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
AL - Albania 3
CR - Costa Rica 3
LB - Libano 3
NP - Nepal 3
SK - Slovacchia (Repubblica Slovacca) 3
YE - Yemen 3
AZ - Azerbaigian 2
BG - Bulgaria 2
DK - Danimarca 2
HN - Honduras 2
KZ - Kazakistan 2
RO - Romania 2
RS - Serbia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BM - Bermuda 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
EU - Europa 1
GD - Grenada 1
GT - Guatemala 1
GY - Guiana 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LV - Lettonia 1
LY - Libia 1
MM - Myanmar 1
NO - Norvegia 1
OM - Oman 1
Totale 13.973
Città #
Singapore 1.073
San Jose 678
Chandler 605
Jacksonville 511
Dublin 477
Ashburn 473
Izmir 282
Beijing 259
Dearborn 233
Dallas 227
Chieti 213
Southend 198
Princeton 194
Nanjing 150
The Dalles 136
Santa Clara 132
Los Angeles 130
Ann Arbor 119
Ho Chi Minh City 112
Kraków 108
Cambridge 103
Wilmington 96
New York 82
Council Bluffs 73
Hanoi 69
Nanchang 66
Pescara 65
Altamura 62
Vienna 56
Tongling 55
Buffalo 54
Munich 53
Moscow 49
Boardman 47
Bosa 40
Houston 40
São Paulo 40
Hong Kong 39
Warsaw 37
Orem 34
Shenyang 34
Atlanta 33
Teramo 33
Woodbridge 32
Hebei 31
Helsinki 31
Jiaxing 30
Brooklyn 29
Kocaeli 28
Redondo Beach 28
Tianjin 28
Chennai 26
Denver 26
Kunming 26
Tokyo 26
Jinan 25
Montreal 24
Rome 24
Toronto 24
Brno 23
Hefei 23
Brussels 22
Milan 22
Changsha 21
Ottawa 21
Washington 21
Da Nang 20
London 20
Stockholm 20
Fairfield 19
Hangzhou 18
Ningbo 18
Poplar 16
Frankfurt am Main 15
Turku 15
Nuremberg 14
Haiphong 13
Johannesburg 13
Rio de Janeiro 13
Bologna 12
Falls Church 12
Guangzhou 12
Mexico City 12
Norwalk 12
Phoenix 12
Ankara 11
Dong Ket 11
San Francisco 11
Seattle 11
Amsterdam 10
Biên Hòa 10
Chicago 10
Como 10
New Delhi 10
Augusta 9
Manchester 9
Mumbai 9
Orange 9
Zhengzhou 9
Auburn Hills 8
Totale 8.594
Nome #
Valutazione biologica e computazionale di inibitori della Ossido Nitrico Sintasi 251
Anticancer Activity of Stilbene-Based Derivatives 193
Synthesis of 2-aryloxypropanoic acids analogues of clofibric acid and assignment of the absolute configuration by 1H NMR spectroscopy and DFT calculations 192
Synthesis and antibacterial evaluation of oxazolidin-2-ones structurally related to linezolid 189
Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-L-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma 188
Amidine N-sostituite come potenziali inibitori delle Ossido Nitrico Sintasi 178
Valutazione biologica dei derivati dell'acido clofibrico come potenziali ligandi PPARs 178
Synthesis, biological activity, and docking studies of novel acetamidines as selective modulators of nitric oxide synthase 172
Titanium-Promoted Acylation of Sulfonamides to N-Acylsulfonamide PPAR Antagonists 171
Hemopressin peptides as modulators of the endocannabinoid system and their potential applications as therapeutic tools 171
Synthesis and Biological Evaluation of 2-Heteroarylthioalkanoic Acid Analogues of Clofibric Acid as Peroxisome Proliferator-Activated Receptor alfa Agonists 167
Synthesis and structure-activity relationships of fibrate-based analogues inside PPARs 167
Recent developments of amidine-like compounds as selective NOS inhibitors 167
Antiglioma Activity of Aryl and Amido-Aryl Acetamidine Derivatives Targeting iNOS: Synthesis and Biological Evaluation 164
Synthesis and biological evaluation of potential Nitric Oxide Synthase inhibitors 163
Novel Phenyldiazenyl Fibrate Analogues as PPAR α/γ/δ Pan-Agonists for the Amelioration of Metabolic Syndrome 161
Benzothiazole-based N-(phenylsulfonyl)amides as a novel familyof PPARa antagonists 160
Synthesis of benzothiazolyl-thioalkanoic acids and pharmacological evaluation on PPARa 159
Determinazione della configurazione assoluta di acidi carbossilici a-sostituiti di interesse farmaceutico attraverso spettroscopia NMR 159
Cytotoxic effect of a family of Peroxisome Proliferator-Activated Receptor antagonists in colorectal and pancreatic cancer cell lines 159
Candida rugosa lipase-catalysed kinetic resolution of 2-substituted-aryloxyacetic esters with dimethylsulfoxide and isopropanol as additives 157
Asymmetric Synthesis of Arylpropionic Acids and Aryloxy Acids by Using Lactamides as Chiral Auxiliaries 157
Discovery of new FXR agonists based on 6-ECDCA binding properties by virtual screening and molecular docking 157
The Selective Acetamidine-Based iNOS Inhibitor CM544 Reduces Glioma Cell Proliferation by Enhancing PARP-1 Cleavage In Vitro 157
Enantiomeric separation of Gemfibrozil chiral analogues by capillary electrophoresis with heptakis(2,3,6-tri-O-methyl)-beta-cyclodextrin as chiral selector 156
Synthesis and biological evaluation of gemfibrozil chiral analogs as potential PPARa agonists 150
Druggability profile of stilbene-derived PPAR agonists: Determination of physicochemical properties and PAMPA study 150
PPARα agonists based on stilbene and its bioisosteres: Biological evaluation and docking studies 148
Syntesis and pharmacological evaluation of fibrates analogues as cardiovascular agents 146
Synthesis and biological characterization of 3-(imidazol-1-ylmethyl)piperidine sulfonamides as aromatase inhibitors 146
Fibrate-derived N-(methylsulfonyl)amides with antagonistic properties on PPARa 145
Synthesis and cytotoxic effects on pancreatic cancer cells of resveratrol analogs 144
Synthesis and antiplatelet activity of clofibric acid analogues 141
Sintesi e valutazione biologica di analoghi eterociclici del gemfibrozil a potenziale attività cardiovascolare 141
Synthetic Strategies to Serine-Proline Chimeras: An Overview 140
Synthesis, biological evaluation and docking studies of N-substituted acetamidines as selective inhibitors of inducible nitric oxide synthase 139
Indazole, Pyrazole, and Oxazole Derivatives Targeting Nitric Oxide Synthases and Carbonic Anhydrases 139
Sulfonimide and Amide Derivatives as Novel PPARα Antagonists: Synthesis, Antiproliferative Activity, and Docking Studies 137
Convergent Solution Phase and Solid Phase Synthesis for the Preparation of beta- Lactam antibiotic libraries. 136
Synthesis of naphthyl-, quinolin- and anthracenyl analogues of clofibric acid as PPARα agonists 136
Synthesis and biological evaluation of new acetamidines as selective inhibitors of Nitric Oxide Synthases 134
Selective Acetamidine-Based Nitric Oxide Synthase Inhibitors: Synthesis, Docking, and Biological Studies 134
Amidine-Based Compounds Affecting L-Arginine Metabolism 134
Selective inhibition of inducible Nitric Oxide Synthase by derivatives of acetamidine 133
Novel aminobenzyl-acetamidine derivative modulate the differential regulation of NOSs in LPS induced inflammatory response: Role of PI3K/Akt pathway 132
Fibrate-based N-acylsulphonamides targeting carbonic anhydrases: synthesis, biochemical evaluation, and docking studies 131
Discovery of gemfibrozil analogues that activate PPARa and enhance the expression of gene CPT1A involved in fatty acids catabolism 130
Starting a new series of acetamidines as Nitric Oxide Sinthase inhibitors 129
Amidine-Based Bioactive Compounds for the Regulation of Arginine Metabolism 129
Dynamic kinetic resolution of α-bromoesters containing lactamides as chiral auxiliaries 128
Analoghi eterociclici dell’acido clofibrico: sintesi, attività antiaggregante piastrinica e separazione in elettroforesi capillare 128
null 128
Synthesis, characterization and evaluation of gemfibrozil-stilbene hybrid as antioxidant agent 128
Multitarget PPARγ agonists as innovative modulators of the metabolic syndrome 128
Structural development studies of PPARs ligands based on tyrosine scaffold 127
Synthesis and biological evaluation of novel acetamidines as nitric oxide inhibitors 126
The excitation-contraction coupling on C2C12 skeletal muscle myotubes was modulated by NO-donor ester of gemfibrozil 126
Advancements in the Research of New Modulators of Nitric Oxide Synthases Activity 125
Benzothiazole Derivatives Endowed with Antiproliferative Activity in Paraganglioma and Pancreatic Cancer Cells: Structure-Activity Relationship Studies and Target Prediction Analysis 125
Dual-PPAR agonists based on stilbene scaffold: synthesis and biological evaluation 125
Selective Inhibition of iNOS by Benzyl- and Dibenzyl Derivatives of N-(3-Aminobenzyl)acetamidine. 124
N-Substituted acetamidines and 2-methylimidazole derivatives as selective inhibitors of neuronal nitric oxide synthase 123
Sintesi di esteri del gemfibrozil donatori di ossido nitrico 123
Targeting neuronal nitric oxide synthase as a valuable strategy for the therapy of neurological disorders 123
Platelet aggregation: synthesis and pharmacological evaluation of clofibric acid analogues 121
Design, synthesis and biological activity of selective hCAs inhibitors based on 2-(benzylsulfinyl)benzoic acid scaffold 121
Synthesis of potential dual binding site acetylcholinesterase inhibitors through an efficient solid phase approach based on the Mitsunobu reaction 121
Effect of stilbene and chalcone scaffolds incorporation in clofibric acid on PPARα agonistic activity 120
Selective inhibition of iNOS by benzyl- and dibenzyl derivatives of N-(3-aminobenzyl)acetamidine on cellular line H2C9 119
New amidine-benzenesulfonamides as iNOS inhibitors for the therapy of the triple negative breast cancer 117
Synthetic methodologies for the preparation of arginine-proline derivatives 117
Synthesis and cytotoxicity evaluation of novel amide and sulfonimide PPARa antagonists 117
Design, synthesis and biological evaluation of imidazole and triazole-based carbamates as novel aromatase inhibitors 112
Design, synthesis and biological evaluation of aromatase inhibitors based on sulfonates and sulfonamides of resveratrol 112
Sintesi di derivati eterociclici dell’acido clofibrico a potenziale attività antiaggregante piastrinica 111
A Novel Prodrug of a nNOS Inhibitor with Improved Pharmacokinetic Potential 111
Novel Phenyldiazenyl Fibrate Analogues as PPAR Agonists: Design, Synthesis and Pharmacological Evaluation 110
Synthesis, biological evaluation, and docking study of indole aryl sulfonamides as aromatase inhibitors 110
Synthesis of novel benzothiazole amides: Evaluation of PPAR activity and anti-proliferative effects in paraganglioma, pancreatic and colorectal cancer cell lines 110
In vitro protective effects of resveratrol and stilbene alkanoic derivatives on induced oxidative stress on c2c12 and mcf7 cells 109
Targeting iNOS As a Valuable Strategy for the Therapy of Glioma 109
Capillary electrophoretic enantioseparation of gemfibrozil analogues by use of TM-b-cyclodextrin as chiral selector 108
Azobenzene as Multi-Targeted Scaffold in Medicinal Chemistry 107
N-substituted acetamidines as nitric oxide synthase inhibitors 107
Choline Chloride-Based DES as Solvents/Catalysts/Chemical Donors in Pharmaceutical Synthesis 107
Design, synthesis and biological evaluation of novel acetamidines as selective inducible nitric oxide synthase inhibitors 106
Azobenzenesulfonamide Carbonic Anhydrase Inhibitors as New Weapons to Fight Helicobacter pylori: Synthesis, Bioactivity Evaluation, In Vivo Toxicity, and Computational Studies 105
Methods to Evaluate the Activity of Nitric Oxide Synthase 105
“Insight into diastereospecific solvolysis of peptidyl-b-lactams: combined kinetic and conformational studies” 105
Reversed-phase high-performance liquid chromatography method with fluorescence detection to screen nitric oxide synthases inhibitors. 103
Synthesis, structure-activity relationships and molecular docking studies of phenyldiazenyl sulfonamides as aromatase inhibitors 103
CAPE derivatives: Multifaceted agents for chronic wound healing 102
Fibrate-Based Analogues as PPARs Agonists: Synthesis and Structure–Activity Relationships 102
Acetamidine-Based iNOS Inhibitors as Molecular Tools to Counteract Inflammation in BV2 Microglial Cells 102
QSAR, QSPR and QSRR in terms of 3-D-MoRSE descriptors for in silico screening of clofibric acid analogues 101
A novel life for antitumor combretastatins: Recent developments of hybrids, prodrugs, combination therapies, and antibody-drug conjugates 98
Screening of NOS activity and selectivity of newly synthesized acetamidines using RP-HPLC 98
In vitro evaluation of a new selective iNOS inhibitor on normal rat astrocytes and C6 rat glioma cells 96
Insights into diastereospecific solvolysis of peptidyl-beta-lactams: combined kinetic and conformational studies 93
N-Acylsulfonylamides as a new class of PPARa antagonists 91
Totale 13.390
Categoria #
all - tutte 53.782
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.782


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202150 0 0 0 0 0 0 0 0 0 0 0 50
2021/2022661 13 13 22 105 70 18 24 49 97 30 71 149
2022/20231.712 124 243 127 169 162 345 88 129 213 21 56 35
2023/2024791 56 26 73 21 48 250 192 10 3 30 8 74
2024/20252.063 92 394 348 46 37 95 116 124 176 94 269 272
2025/20264.601 354 150 411 600 538 263 808 306 477 377 222 95
Totale 14.595